These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

291 related items for PubMed ID: 15582080

  • 1. A randomized controlled trial of combined 5-fluorouracil and low-molecular-weight heparin in management of established proliferative vitreoretinopathy.
    Charteris DG, Aylward GW, Wong D, Groenewald C, Asaria RH, Bunce C, PVR Study Group.
    Ophthalmology; 2004 Dec; 111(12):2240-5. PubMed ID: 15582080
    [Abstract] [Full Text] [Related]

  • 2. Randomized controlled trial of combined 5-Fluorouracil and low-molecular-weight heparin in the management of unselected rhegmatogenous retinal detachments undergoing primary vitrectomy.
    Wickham L, Bunce C, Wong D, McGurn D, Charteris DG.
    Ophthalmology; 2007 Apr; 114(4):698-704. PubMed ID: 17398320
    [Abstract] [Full Text] [Related]

  • 3. Triamcinolone acetonide in silicone-filled eyes as adjunctive treatment for proliferative vitreoretinopathy: a randomized clinical trial.
    Ahmadieh H, Feghhi M, Tabatabaei H, Shoeibi N, Ramezani A, Mohebbi MR.
    Ophthalmology; 2008 Nov; 115(11):1938-43. PubMed ID: 18584876
    [Abstract] [Full Text] [Related]

  • 4. Combined 5-fluorouracil, low-molecular-weight heparin, and silicone oil in the management of complicated retinal detachment with proliferative vitreoretinopathy grade C.
    Garcia RA, Sanchez JG, Arevalo JF.
    Ophthalmic Surg Lasers Imaging; 2007 Nov; 38(4):276-82. PubMed ID: 17674917
    [Abstract] [Full Text] [Related]

  • 5. Outcomes of vitrectomy with inferior retinectomy in patients with recurrent rhegmatogenous retinal detachments and proliferative vitreoretinopathy.
    Quiram PA, Gonzales CR, Hu W, Gupta A, Yoshizumi MO, Kreiger AE, Schwartz SD.
    Ophthalmology; 2006 Nov; 113(11):2041-7. PubMed ID: 16952397
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Silicone oil in the repair of pediatric complex retinal detachments: a prospective, observational, multicenter study.
    Scott IU, Flynn HW, Azen SP, Lai MY, Schwartz S, Trese MT.
    Ophthalmology; 1999 Jul; 106(7):1399-407; discussion 1407-8. PubMed ID: 10406629
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Retinal detachment repair by vitrectomy: simplified formulae to estimate the risk of failure.
    Wickham L, Bunce C, Wong D, Charteris DG.
    Br J Ophthalmol; 2011 Sep; 95(9):1239-44. PubMed ID: 21325394
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. PVR recurrence and the timing of silicon oil removal.
    Halberstadt M, Domig D, Kodjikian L, Koerner F, Garweg JG.
    Klin Monbl Augenheilkd; 2006 May; 223(5):361-6. PubMed ID: 16705505
    [Abstract] [Full Text] [Related]

  • 15. [Treatment of vitreoretinal proliferation in rhegmatogenous detachment and silicone oil tamponade].
    Berrod JP, Sellier A, Rozot P, Raspiller A.
    J Fr Ophtalmol; 1996 May; 19(2):97-105. PubMed ID: 8731777
    [Abstract] [Full Text] [Related]

  • 16. [Application of silicone oil in management of complicated retinal detachment surgery].
    Gao RL, Lu L, Zhang SC.
    Zhonghua Yan Ke Za Zhi; 1994 May; 30(3):201-3. PubMed ID: 7843001
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. A new heavy silicone oil (HWS 46-3000) used as a prolonged internal tamponade agent in complicated vitreoretinal surgery: a pilot study.
    Rizzo S, Genovesi-Ebert F, Vento A, Cresti F, Di Bartolo E, Belting C.
    Retina; 2007 Jun; 27(5):613-20. PubMed ID: 17558325
    [Abstract] [Full Text] [Related]

  • 19. Vitrectomy with silicone oil or long-acting gas in eyes with severe proliferative vitreoretinopathy: results of additional and long-term follow-up. Silicone Study report 11.
    Abrams GW, Azen SP, McCuen BW, Flynn HW, Lai MY, Ryan SJ.
    Arch Ophthalmol; 1997 Mar; 115(3):335-44. PubMed ID: 9076205
    [Abstract] [Full Text] [Related]

  • 20. Heavy silicone oil versus standard silicone oil as vitreous tamponade in inferior PVR (HSO Study): design issues and implications.
    Joussen AM, Kirchhof B, Schrage N, Ocklenburg C, Hilgers RD, HSO Study Group.
    Acta Ophthalmol Scand; 2007 Sep; 85(6):623-30. PubMed ID: 17408389
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.